Powerful New Antibody Neutralizes All Known Covid Variants
Arthur T Knackerbracket has processed the following story:
The antibody could greatly improve our ability to defend against future variants.
Therapeutic antibodies that were effective early in the pandemic have lost their efficacy as SARS-CoV-2 has changed and mutated, and more recent variants, particularly Omicron, have learned how to circumvent the antibodies our systems produce in response to vaccinations. We may be able to better guard against possible variations thanks to a new, widely neutralizing antibody created at Boston Children's Hospital. In tests, it neutralized all known SARS-CoV-2 variants of concern, including all Omicron variants.
We hope that this humanized antibody will prove to be as effective at neutralizing SARS-CoV-2 in patients as it has proven to be thus far in preclinical evaluations," says Frederick Alt, Ph.D., of the Program in Cellular and Molecular Medicine at Boston Children's Hospital, who co-led the research.
In a study that was published in Science Immunology, Alt and Sai Luo, Ph.D., utilized a modified version of a humanized mouse model that his lab had previously used to look for broadly neutralizing antibodies to HIV, another virus that often mutates. Since the mice effectively have built-in human immune systems, the model closely resembles how the trial-and-error process our immune system uses to create increasingly effective antibodies.
The researchers initially introduced two human gene segments into the mice, causing their B cells to create a wide repertoire of humanized antibodies in a short period of time. They subsequently exposed the mice to the original Wuhan-Hu-1 strain of the virus's SARS-CoV-2 spike protein, which is the main protein targeted by our antibodies and current vaccines. The modified mice developed nine lineages, or families," of humanized antibodies that bonded to the spike in response.
Journal Reference:
Sai Luo, Jun Zhang, Alex J.B. Kreutzberger, et aj. An Antibody from Single Human VH-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion 11 August 2022, Science Immunology. DOI: 10.1126/sciimmunol.add5446
Read more of this story at SoylentNews.